文献速递炎症性肠病

系统综述与荟萃分析:局限性溃疡性结肠炎的近端疾病扩展

Systematic review with meta-analysis: proximal disease extension in limited ulcerative colitis.
PubMed 文献 · Aliment Pharmacol Ther · 2017-04-27

该系统综述与荟萃分析纳入41项研究进行系统综述、其中30项进入荟萃分析,评估局限性溃疡性结肠炎患者的疾病扩展频率。汇总扩展频率为22.8%,结肠扩展5年时为17.8%、10年时为31%;18岁以下患者扩展率29.2%显著高于较年长患者的20.2%(P<.0001),北美患者37.8%显著高于欧洲患者19.6%(P<.0001)。

要点

  • 局限性溃疡性结肠炎总体扩展频率为22.8%,扩展多发生在诊断后10年内。
  • 18岁以下患者扩展率29.2%,显著高于较年长患者的20.2%(P<.0001)。
  • 北美患者扩展风险37.8%,显著高于欧洲患者的19.6%(P<.0001)。

核心结论

  • 约四分之一的局限性溃疡性结肠炎患者随时间发生疾病扩展,多数扩展发生在最初10年内。
  • 疾病扩展率取决于诊断时年龄和地理来源。
  • 从诊断时预测疾病扩展高风险患者可能有助于制定个体化治疗策略。

研究设计与样本

  • 系统综述与荟萃分析,系统检索关于溃疡性结肠炎疾病扩展及疾病进展预测因素的研究。
  • 41项研究符合系统综述纳入标准,仅30项进入荟萃分析。

主要发现

  • 溃疡性结肠炎总体汇总扩展频率为22.8%。
  • 结肠扩展频率5年时为17.8%,10年时为31%。
  • 从E1扩展至E3为17.8%(95%CI 11.2-27.3),从E2扩展至E3为27.5%(95%CI 7.6-45.6),从E1扩展至E2为20.8%(95%CI 11.4-26.8)。
  • 18岁以下患者扩展率为29.2%(CI 6.4-71.3),较年长患者为20.2%(CI 13.0-30.1),差异显著(P<.0001)。
  • 北美患者扩展风险为37.8%,欧洲患者为19.6%,差异显著(P<.0001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Disease extent in ulcerative colitis is one of the major factors determining prognosis over the long-term. Disease extent is dynamic and a proportion of patients presenting with limited disease progress to more extensive forms of disease over time. AIM: To perform a systematic review and meta-analysis of epidemiological studies reporting on extension of ulcerative colitis to determine frequency of disease extension in patients with limited ulcerative colitis at diagnosis. METHODS: We performed a systematic literature search to identify studies on disease extension of ulcerative colitis (UC) and predictors of disease progression. RESULTS: Overall, 41 studies were eligible for systematic review but only 30 for meta-analysis. The overall pooled frequency of UC extension was 22.8% with colonic extension being 17.8% at 5 years and 31% at 10 years. Extension was 17.8% (95% CI 11.2-27.3) from E1 to E3, 27.5% (95% CI 7.6-45.6) from E2 to E3 and 20.8% (95% CI 11.4-26.8) from E1 to E2. Rate of extension was significantly higher in patients younger than 18 years (29.2% (CI 6.4-71.3) compared to older patients (20.2% (CI 13.0-30.1) (P<.0001). Risk of extension was significantly higher in patients from North America (37.8%) than from Europe (19.6%) (P<.0001). CONCLUSIONS: In this meta-analysis, approximately one quarter of patients with limited UC extend over time with most extension occurring during the first 10 years. Rate of extension depends on age at diagnosis and geographic origin. Predicting those at high risk of disease extension from diagnosis could lead to personalised therapeutic strategies.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Roda G, Narula N, Pinotti R, et al. Systematic review with meta-analysis: proximal disease extension in limited ulcerative colitis. Aliment Pharmacol Ther. 2017. PMID: 28449361. doi:10.1111/apt.14063

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。